The Company intends to combine with a pharmaceutical or healthcare-focused business with a strong access to transformative technology and an enterprise value of approximately $250.0 million to $1.0 billion. Aesther Healthcare is led by Chairman and CEO Suren Ajjarapu and CFO and Secretary Howard A. Doss.
Total SPAC deal count for 2021 year-to-date is now 432. This offering is expected to close on Friday, September 17.
EF Hutton, a division of Benchmark Investments, LLC, served as the sole book-running manager on the offering. The Loev Law Firm, PC is serving as Issuer’s Counsel with Schiff Hardin LLP serving as Underwriter’s Counsel. MaloneBailey, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.